CIK 0001368514
- Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562590442
- Phone
- +1 201-478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,191,320
- in 3 filings, $2.1M under 10b5-1 plans
Net −$2,191,320. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-02-13 | ELMS STEVE Director | Grant or award | +2,516,855 | 2,516,855 | ||
| 2012-02-13 | GOLDSTEIN DOV A MD Director | Grant or award | +2,516,855 | 2,516,855 | ||
| 2012-02-13 | WARSHAW KIRK M CFO, Secretary | Returned to the company | −94,792 | 5,208 | ||
| 2012-02-13 | R & R INVESTMENTS VI LLC 10% owner | Returned to the company | +1,960,660 | 39,340 | ||
| 2012-02-13 | KLING ARNOLD P President | Returned to the company | −391,515 | 8,485 |
Page 32 of 32 · 625 trades